Knightsbridge Asset Management’s Novartis NVS Stock Holding History

Knightsbridge Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$838K	Sell	5,345 -38	-0.7%	-$5.7K	0.11%	102
2026 Q1	$822K	Buy	5,383 +1,059	+24%	+$162K	0.11%	96
2025 Q4	$596K	Buy	4,324 +219	+5%	+$28.7K	0.1%	96
2025 Q3	$526K	Sell	4,105 -145	-3%	-$17.7K	0.09%	93
2025 Q2	$514K	Buy	4,250 +576	+16%	+$64.9K	0.11%	87
2025 Q1	$410K	Sell	3,674 -177	-5%	-$18.8K	0.11%	92
2024 Q4	$375K	Buy	3,851 +457	+13%	+$48.7K	0.09%	96
2024 Q3	$390K	Buy	3,394 +240	+8%	+$27.2K	0.09%	92
2024 Q2	$336K	Buy	3,154 +713	+29%	+$71.6K	0.08%	93
2024 Q1	$247K	Hold	2,441	–	–	0.07%	105
2023 Q4	$247K	Buy	+2,441	New	+$236K	0.07%	105
2023 Q2	–	Sell	-2,636	Closed	-$243K	–	121
2023 Q1	$243K	Sell	2,636 -64	-2%	-$5.59K	0.04%	119
2022 Q4	$245K	Buy	+2,700	New	+$227K	0.05%	120

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Knightsbridge Asset Management's NVS Position: Q2 2026 in Review

Knightsbridge Asset Management reduced its Novartis (NVS) stake by 0.71% in Q2 2026, selling an estimated $5.7K and leaving 5,345 shares worth $838K. The position accounts for 0.11% of the portfolio, ranked #102.

Knightsbridge Asset Management first reported a position in NVS in Q4 2022 and has held it in 13 quarters since. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Knightsbridge Asset Management held 5,345 shares of Novartis worth $838K as of Q2 2026.
Knightsbridge Asset Management sold 38 Novartis shares in Q2 2026, an estimated $5.7K.
Novartis made up 0.11% of Knightsbridge Asset Management's portfolio in Q2 2026, its #102 holding.
Knightsbridge Asset Management first reported a position in Novartis in Q4 2022 and has held it in 13 quarters since.
1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Knightsbridge Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.